Isotretinoïne Mylan

Isotretinoin, the active ingredient in Isotretinoïne Mylan, is a retinoid presented as an oral dosage form for oral use. It treats severe nodular acne and recalcitrant acne in patients who have not responded to other therapies.

GNH USA supplies Isotretinoïne Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotretinoin is a retinoid indicated for severe forms of acne that are resistant to conventional therapy. - Severe nodular acne: markedly reduces inflammatory nodules and prevents formation of new lesions. - Recalcitrant acne not responding to other therapies: achieves significant skin clearance when standard treatments fail. - Severe inflammatory acne: diminishes papules, pustules and cystic lesions, improving overall skin appearance.

Isotretinoïne Mylan may cause a range of adverse reactions, most of which are dose‑related and reversible after discontinuation.

Common Side Effects: - Dry skin and mucous membranes: excessive dryness of skin, lips and eyes. - Cheilitis: cracking and inflammation of the lips. - Elevated liver enzymes: mild, transient increases in hepatic transaminases. - Hypertriglyceridemia: rise in blood triglyceride levels.

Serious or Rare Side Effects: - Severe depression or suicidal ideation: mood changes requiring immediate medical attention. - Inflammatory bowel disease: new onset or exacerbation of Crohn's disease or ulcerative colitis. - Teratogenic birth defects: severe congenital malformations if exposure occurs during pregnancy. - Pancreatitis: acute inflammation of the pancreas, presenting with abdominal pain and elevated enzymes.

Isotretinoïne Mylan requires careful monitoring and patient counseling due to its potent pharmacologic profile. - Pregnancy contraindication: teratogenic risk mandates strict contraception for females of child‑bearing potential. - Liver function monitoring: baseline and periodic liver enzyme tests are recommended. - Lipid profile monitoring: assess triglycerides and cholesterol before and during therapy. - Mood and psychiatric assessment: watch for signs of depression, anxiety or suicidal thoughts. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Isotretinoïne Mylan can alter the safety or efficacy of several concomitant medicines.

Major Interactions (Avoid): - Tetracycline antibiotics: increased risk of intracranial hypertension. - Vitamin A supplements: additive retinoid toxicity. - Systemic retinoids (e.g., acitretin): cumulative teratogenic and hepatic toxicity.

Moderate Interactions (Monitor Closely): - Oral corticosteroids: may exacerbate mood changes. - Anticoagulants (warfarin): potential alteration of INR values. - Phenobarbital and other enzyme inducers: may reduce isotretinoin plasma concentrations.